Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Th. Senge"'
Publikováno v:
Mycoses. 13:435-438
Zusammenfassung Innerhalb eines halben Jahres haben wir bei neun Kindern – unter ihnen waren sechs Sauglinge bzw. Kriedilinge – eine Harnwegsinfektion durch Sprospilze diagnostiziert. Moglicherweise handelte es sich bei einigen von ihnen um eine
Publikováno v:
The Prostate. 58:121-129
INTRODUCTION The complexity of acute and chronic inflammatory processes may either lead to benign prostate hyperplasia (BPH) and/or prostate cancer. Obviously, various tissue cells are activated by chemokines via different chemotaxin receptors which
Publikováno v:
Aktuelle Urologie. 30:78-88
Publikováno v:
International Urology and Nephrology. 29:637-643
To study the impact of radical tumour surgery in prostate and renal cell cancer patients on quality of life (QOL). In 38 male patients suffering from organ-confined prostate or renal cell cancer, a prospective study was performed. For the evaluation
Publikováno v:
Journal of Urology. 158:497-501
Purpose: We analyzed the efficacy and side effects of a microprocessor controlled high frequency unit for transurethral resection of the prostate.Materials and Methods: A high frequency device with microprocessor control was used in 934 consecutive p
Publikováno v:
Aktuelle Urologie. 27:75-78
Autor:
G. Haupt, Jeffrey A. Jones, Th. Senge, J. Pastor, Richard S. Foster, John P. Donohue, C. de Riese, William N. Crabtree, W. de Riese
Publikováno v:
International Urology and Nephrology. 27:603-613
Current clinical staging which includes serum tumour markers and imaging techniques fails to identify 30-40% of clinical stage I nonseminomatous germ cell testicular tumour (NSGCT) patients who have occult metastatic disease at time of orchiectomy an
Publikováno v:
The Lancet. 345:1529-1532
Medical treatments have become available for benign hypertrophy of the prostate, including alpha-receptor blocking agents and 5-alpha-reductase inhibitors. Drugs derived from plants, for which no precise mechanism of action has been described, are wi
Publikováno v:
Aktuelle Urologie. 26:200-203
Autor:
Edwin B. Walker, W. N. Crabtree, C. de Riese, John P. Donohue, W. de Riese, Andreas Hinkel, Th. Senge, Jeffrey A. Jones, Richard S. Foster, Thomas M. Ulbright, Jonathan E. Messemer
Publikováno v:
Urological Research. 22:213-220
Current clinical staging, which includes the use of serum tumor markers and imaging techniques, fails to identify the 30-40% of clinical stage I (CS I) nonseminomatous germ cell testicular tumor (NSGCT) patients who have occult metastatic disease. Th